NCT05874622View on ClinicalTrials.gov

A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 12, 2023

Primary Completion Date

October 18, 2023

Study Completion Date

October 25, 2023

Conditions
Rheumatoid Arthritis
Interventions
DRUG

VC005 tablets

VC005 groups repeat administration for 4 weeks

DRUG

VC005 Tablets Placebo

VC005 placebo groups repeat administration for 4 weeks

Trial Locations (1)

130061

The First Bethune Hospital of Jilin University, Changchun

All Listed Sponsors
lead

Jiangsu vcare pharmaceutical technology co., LTD

INDUSTRY

NCT05874622 - A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis. | Biotech Hunter | Biotech Hunter